Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 4/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720831 | 0.90 | HRH3 (0.42) | SRD5A2HRH3MCHR1 | |
| SCHEMBL14720522 | 0.84 | HRH3 (0.39) | SRD5A2HRH3MCHR1CHRM2CHRM1 | |
| SCHEMBL14721351 | 0.84 | MCHR1 (0.40) | SRD5A2HRH3SRD5A1MCHR1 | |
| SCHEMBL14721353 | 0.84 | SRD5A2 (0.42) | SRD5A2HRH3SRD5A1MCHR1 | |
| SCHEMBL14722438 | 0.83 | HRH3 (0.39) | SRD5A2HRH3MCHR1CHRM2CHRM1 | |
| SCHEMBL14720721 | 0.82 | HRH3 (0.36) | SRD5A2HRH3SRD5A1MCHR1 | |
| SCHEMBL14723242 | 0.81 | SRD5A2 (0.47) | SRD5A2HRH3SRD5A1CHRM1 | |
| SCHEMBL14731163 | 0.81 | MCHR1 (0.38) | SRD5A2HRH3SRD5A1MCHR1 | |
| SCHEMBL14720884 | 0.81 | HRH3 (0.36) | SRD5A2HRH3DHODHSRD5A1CHRM2 | |
| SCHEMBL14720787 | 0.81 | SRD5A2 (0.43) | SRD5A2HRH3DHODHMCHR1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | claimed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |